Food supplement
AndroBIO Plus Buste
€28.50
ANDROBIO plus è un integratore alimentare indicato per gli adulti a base di myo-inositolo (4 g/dose giornaliera), fitosteroli (286 mg fitosteroli/dose giornaliera), biotina e zinco. La biotina e lo zinco contribuiscono al mantenimento di pelle e capelli normali. Inoltre lo zinco contribuisce al mantenimento di normali livelli di testosterone nel sangue.
Gluten and lactose free product
Si consiglia l’assunzione di un bustina (4,5 g) una volta al giorno da sciogliere in 100 ml di acqua. Mescolare bene, almeno 30 secondi, fino a completa solubilizzazione.
myo-inositolo, fitosteroli (di cui 70% beta-sitosterolo), agente antiagglomerante: biossido di silicio; acidificante: acido citrico; SunActive® Zn (ossido di zinco, emulsionanti: esteri poligliceridi degli acidi grassi, lecitina di SOIA; maltodestrina), aroma, colorante: caroteni; edulcorante: sucralosio; D-biotina. SunActive® è un marchio registrato di Taiyo Kagaku Co.



ANDROBIO Plus
Riequilibrante ormonale UOMO-DONNA
-
Myo-inositol
Inositol is a carbocyclic polyol, the important form of which in nature is the myo-inositol.
-
Beta-sitosterol
It is a phytosterol, that is a plant sterol with a structure similar to that of cholesterol, rather widespread among genetic species, in particular it is present in some plants used to regulate sexual steroids, such as Saw palmetto (serenoa repens).
-
Zinc SunActive®
Zinc is involved in over 300 enzymatic reactions. It carries out a structural activity, given its presence in structural proteins and in the phospholipid bilayer which constitutes cell membranes. It has a modulating action, regulating the expression of numerous genes involved in cell proliferation, differentiation and death. SunActive ZN is an innovative high absorption liposomal technology.
-
Biotin
All the B vitamins, and therefore also biotin (vitamin H), help the body to transform the carbohydrates we take into glucose and therefore a obtain useful energy for the body.

Myo-inositol in Gynecology
Polycystic ovary syndrome (PCOS) is a multifactorial disease that affects 5-10% of women of childbearing age and is considered the most common endocrine alteration in childbearing age. It is characterized by enlargement of the ovaries, by the presence of multiple ovarian cysts and by endocrinological and metabolic alterations (hyperandrogenism, insulin resistance and resulting hyperinsulinemia). It is a complex functional alteration of the reproductive system given by the increase in male hormones (androgens). Several studies have shown the effectiveness of myo-inositol in reducing alterations oxidative, hormonal, metabolic of patients with PCOS, improving their insulin resistance.
Menstrual irregularity, reduced fertility
Hirsutism and acne
Alopecia, weight gain, heart disease